Recap: Lexicon Pharmaceuticals Q3 Earnings

Lexicon Pharmaceuticals LXRX reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Lexicon Pharmaceuticals their estimated earnings by 11.11%, reporting an EPS of $-0.16 versus an estimate of $-0.18, which surprised analysts.

Revenue was up $6,611,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03, which was followed by a 1.12% drop in the share price the next day.

Here's a look at Lexicon Pharmaceuticals's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.16 -0.16 -0.28 0.26
EPS Actual -0.13 -0.15 -0.04 -0.43
Revenue Estimate 10.00K 1.68M 110.00K 16.87M
Revenue Actual 234.00K 27.00K 199.00K 6.63M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

LXRX Logo
LXRXLexicon Pharmaceuticals Inc
$1.09-3.54%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
30.96
Growth
N/A
Quality
N/A
Value
47.33
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...